Nucana Plc Is A Clinical Stage Biopharmaceutical Company Based In Edinburghunited Kingdomfounded In 1997 And Operational Since 2008Nucana Focuses On Developing Innovative Cancer Therapies Through Its Proprietary Protide Technologythis Technology Modifies Existing Nucleoside Analogs To Enhance Their Effectiveness Against Cancer While Minimizing Toxicity To Healthy Cells The Company S Product Pipeline Includes Nuc 3373A Protide Transformation Of 5 Fluorouracilcurrently In Phase 1B 2 Trials For Metastatic Colorectal Cancer And Other Advanced Solid Tumorsanother Candidatenuc 7738Is A Protide Derivative Of 3Aedeoxyadenosineundergoing Phase 1 2 Trials For Advanced Solid Tumorsincluding Melanoma And Ovarian Cancernucana Collaborates With Cardiff Protides Ltd To Expand Its Drug Discovery Effortsaiming To Improve Patient Outcomes In Oncology
No conferences found for this company.
| Company Name | Nucana Plc |
| Country |
United Kingdom
|
| Address | N/A |
| Telephone | N/A |
| N/A |
